Order:
Disambiguations
Ineke Bolt [9]I. Bolt [2]Ineke L. E. Bolt [1]Ineke L. L. E. Bolt [1]
  1.  79
    The Future of Psychopharmacological Enhancements: Expectations and Policies.Maartje Schermer, Ineke Bolt, Reinoud de Jongh & Berend Olivier - 2009 - Neuroethics 2 (2):75-87.
    The hopes and fears expressed in the debate on human enhancement are not always based on a realistic assessment of the expected possibilities. Discussions about extreme scenarios may at times obscure the ethical and policy issues that are relevant today. This paper aims to contribute to an adequate and ethically sound societal response to actual current developments. After a brief outline of the ethical debate concerning neuro-enhancement, it describes the current state of the art in psychopharmacological science and current uses (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   22 citations  
  2.  21
    The Future of Psychopharmacological Enhancements: Expectations and Policies.M. H. N. Schermer, I. Bolt, R. De Jongh & B. Olivier - 2009 - Neuroethics 2 (2):75-87.
  3. Psychopharmaceutical Enhancers: Enhancing Identity?Ineke Bolt & Maartje Schermer - 2009 - Neuroethics 2 (2):103-111.
    The use of psychopharmaceuticals to enhance human mental functioning such as cognition and mood has raised a debate on questions regarding identity and authenticity. While some hold that psychopharmaceutical substances can help users to ‘become who they really are’ and thus strengthen their identity and authenticity, others believe that the substances will lead to inauthenticity, normalization, and socially-enforced adaptation of behaviour and personality. In light of this debate, we studied how persons who actually have experience with the use of psychopharmaceutical (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  4.  21
    Recent Insights Into Decision-Making and Their Implications for Informed Consent.Irene M. L. Vos, Maartje H. N. Schermer & Ineke L. L. E. Bolt - 2018 - Journal of Medical Ethics 44 (11):734-738.
    Research from behavioural sciences shows that people reach decisions in a much less rational and well-considered way than was often assumed. The doctrine of informed consent, which is an important ethical principle and legal requirement in medical practice, is being challenged by these insights into decision-making and real-world choice behaviour. This article discusses the implications of recent insights of research on decision-making behaviour for the informed consent doctrine. It concludes that there is a significant tension between the often non-rational choice (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  5. Wish-Fulfilling Medicine in Practice: A Qualitative Study of Physician Arguments.Eva C. A. Asscher, Ineke Bolt & Maartje Schermer - 2012 - Journal of Medical Ethics 38 (6):327-331.
    There has been a move in medicine towards patient-centred care, leading to more demands from patients for particular therapies and treatments, and for wish-fulfilling medicine: the use of medical services according to the patient's wishes to enhance their subjective functioning, appearance or health. In contrast to conventional medicine, this use of medical services is not needed from a medical point of view. Boundaries in wish-fulfilling medicine are partly set by a physician's decision to fulfil or decline a patient's wish in (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  6.  35
    The Controversy Over Pediatric Bariatric Surgery: An Explorative Study on Attitudes and Normative Beliefs of Specialists, Parents, and Adolescents With Obesity.Stefan M. van Geelen, Ineke L. E. Bolt, Olga H. van der Baan-Slootweg & Marieke J. H. van Summeren - 2013 - Journal of Bioethical Inquiry 10 (2):227-237.
    Despite the reported limited success of conventional treatments and growing evidence of the effectiveness of adult bariatric surgery, weight loss operations for (morbidly) obese children and adolescents are still considered to be controversial by health care professionals and lay people alike. This paper describes an explorative, qualitative study involving obesity specialists, morbidly obese adolescents, and parents and identifies attitudes and normative beliefs regarding pediatric bariatric surgery. Views on the etiology of obesity—whether it should be considered primarily a medical condition or (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  27
    Introduction.Maartje Schermer & Ineke Bolt - 2009 - Neuroethics 2 (2):61-62.
    The use of psychopharmaceuticals to enhance human mental functioning such as cognition and mood has raised a debate on questions regarding identity and authenticity. While some hold that psychopharmaceutical substances can help users to ‘become who they really are’ and thus strengthen their identity and authenticity, others believe that the substances will lead to inauthenticity, normalization, and socially-enforced adaptation of behaviour and personality. In light of this debate, we studied how persons who actually have experience with the use of psychopharmaceutical (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  4
    Prevention in the Age of Personal Responsibility: Epigenetic Risk-Predictive Screening for Female Cancers as a Case Study.Ineke Bolt, Eline M. Bunnik, Krista Tromp, Nora Pashayan, Martin Widschwendter & Inez de Beaufort - forthcoming - Journal of Medical Ethics:medethics-2020-106146.
    Epigenetic markers could potentially be used for risk assessment in risk-stratified population-based cancer screening programmes. Whereas current screening programmes generally aim to detect existing cancer, epigenetic markers could be used to provide risk estimates for not-yet-existing cancers. Epigenetic risk-predictive tests may thus allow for new opportunities for risk assessment for developing cancer in the future. Since epigenetic changes are presumed to be modifiable, preventive measures, such as lifestyle modification, could be used to reduce the risk of cancer. Moreover, epigenetic markers (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  9. Soorten van Gelijk. Medisch-Ethische Discussies in Nederland.Ineke Bolt, Suzanne Vathorst & M. Trappenburg - 1996 - Filosofie En Praktijk 15:209-209.
    No categories
     
    Export citation  
     
    Bookmark   1 citation  
  10.  11
    Contextualizing Genetic Testing and Sequencing Results for Patients and Parents: The Need for Empirical-Ethical Research.Candice Cornelis, Ineke Bolt & Marieke Van Summeren - 2014 - American Journal of Bioethics 14 (3):10-12.
  11.  7
    ‘We Should View Him as an Individual’: The Role of the Child’s Future Autonomy in Shared Decision-Making About Unsolicited Findings in Pediatric Exome Sequencing.W. Dondorp, I. Bolt, A. Tibben, G. De Wert & M. Van Summeren - 2021 - Health Care Analysis 29 (3):249-261.
    In debates about genetic testing of children, as well as about disclosing unsolicited findings of pediatric exome sequencing, respect for future autonomy should be regarded as a prima facie consideration for not taking steps that would entail denying the future adult the opportunity to decide for herself about what to know about her own genome. While the argument can be overridden when other, morally more weighty considerations are at stake, whether this is the case can only be determined in concrete (...)
    Direct download (2 more)  
    Translate
     
     
    Export citation  
     
    Bookmark  
  12. And the Gray Area Between Treatment and Enhancement.Maartje Schermer & Ineke Bolt - 2011 - In Guy Kahane, Julian Savulescu & Ruud Ter Meulen (eds.), Enhancing Human Capacities. pp. 179.
     
    Export citation  
     
    Bookmark  
  13.  50
    Tailor-Made Pharmacotherapy: Future Developments and Ethical Challenges in the Field of Pharmacogenomics.Johannes Van Delden, Ineke Bolt, Annemarie Kalis, Jeroen Derijks & Hubert Leufkens - 2004 - Bioethics 18 (4):303–321.
    In this article ethical issues are discussed which play a role in pharmacogenetics. Developments in pharmacogenetics have a large impact on many different practices such as clinical trials, the practice of medicine and society at large. In clinical trials, questions rise regarding the exclusion of genetic subgroups that may be non- or poor-responders to the experimental drug. Also, the question is asked how pharmaceutical companies should deal with their growing knowledge about the relations between genetic variation and adverse effects. Moreover, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark